Doc/PA of the Day - Volunteers Needed |
|
The 2022 Legislative Session will convene Monday, February 14th and is scheduled to adjourn on Friday, March 11th.
We need one volunteer each day, Monday - Friday. If you have any questions about the process, please feel free to contact the WMS office.
If you are able to volunteer please email Whitney at whitney@wyomed.org to sign up for a slot or call WMS at 307-635-2424.
|
|
WMS Board of Trustees Meeting |
|
WMS Bylaws specify that all meetings of the WMS Board of Trustees (BoT) are open to active members. The WMS BoT will be at the end of the month to discuss legislative policy positions as well as conduct the other business of the Society.
As always, our members' input is welcome and appreciated.
We do our best work when we have perspectives from across the state and from various specialties.
|
|
Join Zoom Meeting
Meeting ID: 868 677 9131
One tap mobile
+13462487799,,8686779131#
|
|
LCMS Legislative Reception |
|
February 17, 2022 at 6:30 pm at The Met - Cheyenne |
The Laramie County Medical Society would like to invite WMS members to attend their legislative reception on Thursday, February 17 at The Met in downtown Cheyenne.
WMS Director Sheila Bush will be presenting legislative updates to attendees for the 2022 Legislative Session.
Hors d'oeuvres and cocktails will be served at this event. To RSVP, please email Whitney at whitney@wyomed.org.
Please RSVP no later than Wednesday, February 9th.
|
|
HHS releases new Buprenorphine practice guidelines, expanding prescribing authority without DEA certification. |
The U.S. Department of Health and Human Services (HHS) issued updated guidelines that will allow practitioners to administer buprenorphine to treat opioid use disorder (OUD) without U.S. Drug Enforcement Administration (DEA) certification.
This exemption allows practitioners to treat up to 30 patients with OUD using buprenorphine without certain training-related certifications, including the ability to provide counseling and ancillary services. Under this exemption, qualified emergency department practitioners can now administer buprenorphine to begin MAT.
What this means for you
- Qualified practitioners include physicians, nurse practitioners, physician assistants, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse-midwifes.
- This exemption only applies to prescribing Schedule III, IV, and V drugs or a combination of them, including buprenorphine.
- Eligible practitioners are still required to submit a Notice of Intent application to prescribe buprenorphine.
Providers who do not want to practice under this exemption can request a waiver that will allow them to treat more than 30 patients.
|
|
|
|
|
|
It's time to renew your WMS membership!
OR
|
|
UCHealth would like to invite you to participate in Heart Month CME opportunities. Both a FREE and provide CME credits. |
|
Click image to view invite. |
7th Annual Heart and Vascular Virtual Conference
February 15, 2022 from 8am - 2pm
|
|
Click image to view invite. |
Heart Month Virtual Presentation Series
February 3, 2022 from 12pm - 1 pm
February 8, 2022 from 12 pm - 1pm
February 23, 2022 from 12 pm - 1 pm
February 25, 2022 from 12 pm - 1 pm
|
|
Research Survey - Receive $50 |
|
Dr. Emma Levine, Associate Professor of Behavioral Science at the University of Chicago Booth School of Business, is conducting research on how doctors communicate with patients and is interested in your experience! You can participate in this 10-15 minute study in which you will read prompts and answer questions about your experience as a medical professional.
Only medical professionals (non-students) are eligible to participate. As compensation, you will receive a $50 Amazon gift card (or Venmo transfer, whichever you prefer). Please email Emma Levine (Emma.Levine@chicagobooth.edu) if you have any questions.
|
|
|
Texas Medical Association Chart Compares COVID Therapies |
|
To help you compare the National Institutes of Health’s (NIH’s) recommended COVID-19 outpatient therapies, the Texas Medical Association has created a chart with information on each of the four recommended drugs in the NIH’s listed preference order: nirmatrelvir plus ritonavir, sotrovimab, remdesivir, and molnupiravir.
The chart includes dosages, situational considerations (such as whether the patient can continue on the drug if hospitalized during the therapy), contraindications, and more. Also included are links to fact sheets and locators for the treatments.
|
|
Click image to view chart |
|
COVID-19 Immunization Data |
|
Click image to view full sized report. |
|
Here you will find:
- Vaccine program provider enrollment
- Required training for COVID-19 vaccine coordinators
- COVID-19 vaccine resources and information
- COVID-19 vaccination program templates and forms
- CDC's V-Safe After Vaccination Health Checker
- Wyoming Immunization Registry (WyIR) Resources
|
|
Thank you 2021 Friends of WMS! |
|
Thank you to all of the organizations that supported the Wyoming Medical Society in 2021.
The Medical Society could not advocate for our members without the support of these organizations.
WMS members, please keep our partners in mind as you seek services. Their support is instrumental to the continued success of WMS!
|
|
|
|
|
|
|
